Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Pediatr Blood Cancer. 2022 Feb 2;69(5):e29546. doi: 10.1002/pbc.29546

TABLE 2.

Information from the studies

Reference Population age (years) Time range Data source Cancer type
Abrahão et al., 201522 <1–19 1988–2011 California Cancer Registry APL
Abrahão et al., 201523 Only analyzed 0–19 data in review 1988–2011 California Cancer Registry ALL
Acharya et al., 201621 1–18 1995–2008 Florida Cancer Data System, Texas Cancer Registry ALL
Austin et al., 201524 ≤18 1995–2009 Texas Cancer Registry Non-CNS solid tumor malignancy
Austin et al., 201625 ≤18 1995–2009 Texas Cancer Registry CNS
Bona et al., 20167,31 1–18 2000–2010 Dana Farber Cancer Institute ALL
Bona et al., 202041 ≤18 2005–2014 Children’s Oncology Group, High-risk neuroblastoma
Pediatric Health Information System
Bona et al., 202136 ≤18 2006–2015 Center for International Blood and Bone Marrow Transplant Research Generally mentioned “malignant disease”
Byrne et al., 201135 Only included <10, 10–19 data in review 1998–2002 Florida Cancer Data System AML
Colton et al., 201943 Only analyzed 15–19 in review 2007–2014 SEER Lymphoid leukemia, AML, HL, NH: (except Burkitt), astrocytomas, gliomas, hepatic carcinomas, malignant gonadal germ cell tumors, other and unspecified carcinomas
Cooney et al., 201826 0–19 1988–2012 California Cancer Registry High-grade glioma, medulloblastoma
Doganis et al., 201842 0–14 1990–2012 SEER Wilms tumor
Dressler et al., 201737 0–19 1998–2011 NCDB Medulloblastoma
Garner et al., 201739 ≤21 1998–2012 NCDB WDTC
Hamilton et al., 201627 ≤18 1995–2009 Texas Cancer Registry Melanoma
Kehm et al., 201828 0–19 2000–2012 SEER ALL, AML neuroblastoma, NHL, HL, astrocytoma, non-astrocytoma CNS tumors, non-rhabdomyosarcoma soft tissue sarcomas, rhabdomyosarcoma, Wilms tumor, osteosarcoma, germ cell tumors
Kent et al., 200929 0–14 1996–2005 California Cancer Registry Leukemia (ALL, AML, CLL, CML)
Khullar et al., 202038 ≤21 2004–2015 NCDB HL
Knoble et al., 201632 0–19 1973–2012 SEER AML
Lee et al., 201745 <15 2007–2009 SEER Leukemias, lymphomas, CNS neoplasms, neuroblastomas, PNS tumors, retinoblastomas, renal tumors, hepatic tumors malignant tumors, sarcomas, germ cell tumors, malignant epithelial neoplasms
Mitchell et al., 202030 0–19 2000–2015 SEER CNS
Penumarthy et al., 202044 Only analyzed <15 in review 2000–2015 UC San Francisco Cancer Registry Bone and soft tissue sarcomas
Ribeiro et al., 201533 0–19 2000–2009 SEER Langerhans cell histiocytosis
Schraw et al., 2020 <20 1995–2011 Texas Cancer Registry ALL
Siegel et al., 201940 <20 2001–2008 CDC NPCR CNS

Abbreviations: ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; APL, acute promyelocytic leukemia; CDC, Centers for Disease Control and Prevention; CLL, chronic lymphocytic leukemia; CML, chronic myeloid leukemia; CNS, central nervous system; HL, Hodgkin lymphoma; NCDB, National Cancer Database; NHL, non-Hodgkin lymphoma; NPCR, National Program of Cancer Registries; PNS, peripheral nervous system; SEER, Surveillance, Epidemiology, and End Results; WDTC, well-differentiated thyroid cancer.